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Key findings. 
Of IDRS participants:• Around one fifth of both Melbourne (19%) and Sydney (22%) participants
reported that they have used a supervised injecting facility for more than half of
their injections.
• Being away from police was most commonly cited as the main reason to use a
supervised injecting facility (53% Melbourne, 42% in Sydney).
• Fifty percent of Melbourne and 33% of Sydney study participants reported that
distance from their living area is the main reason for not using a supervised
injecting facility.
Introduction
People who inject drugs (PWID) are at increased risk of fatal and non-fatal
overdose, blood-borne viral infections, and a range of negative social and health
consequences (1,2). Interventions such as supervised injecting facilities (SIFs)
have been shown to reduce overdose-related morbidity and mortality, drug-related
risk behaviors, and to improve public amenity (3). The first SIF in Australia, the
Medically Supervised Injecting Centre (MSIC), was opened in 2001 in Sydney's
Kings Cross and is estimated to have saved many lives and minimised health risks
(4). The second facility in Australia, the Melbourne Supervised Injecting Room
(MSIR), was opened in July 2018 and a recent review has seen its trial status
extended for three years (5).
SIFs are designed to benefit vulnerable and marginalised PWID. They have been
shown to attract PWID who often: are unemployed, are living in unstable
accommodation, have low levels of education, have a significant history of
incarceration, inject in public and have a history of non-fatal overdose (6). In the
2019 survey of PWID conducted as part of the Illicit Drug Reporting System
(IDRS), we introduced questions related to SIF use in surveys conducted in
Sydney and Melbourne. In this bulletin, we summarise findings from the Sydney
and Melbourne survey samples who report use of the SIFs in their city.
1
Method
Data were drawn from the survey of PWID conducted as part of the Illicit Drug
Reporting System (IDRS) in 2019. Annually, approximately 800-900 PWID who
report regularly injecting drugs are recruited from all capital cities of Australian
states and territories, through services such as needle and syringe programs as
well as peer-referral. Structured questionnaires are administered to participants in
face-to-face interviews covering a broad range of domains including socio-
demographic characteristics, drug use patterns, drug markets and use of health
and harm reduction services including SIF use. Details on the overall methods of
the IDRS can be found elsewhere (7).
For the purposes of this Bulletin we examined a series of self-reported questions
that were included in relation to SIF use in Sydney (n=152) and Melbourne
(n=183). Descriptive statistics of socio-demographic, drug use characteristics and
SIF use related factors are presented. Comparisons among Sydney and
Melbourne samples were conducted using Pearson's Chi-square Test for
categorical variables and t-tests for continuous variable (age).
Results
Forty-seven per cent of the Melbourne (n=183) and fifty-six per cent of the Sydney
(n=152) sample reported having used the SIF in their lifetime in their respective
city (Figure 1).
Sample socio-demographic and drug use characteristics
Table 1 shows the socio-demographic and drug use related characteristics among
Sydney and Melbourne participants who report SIF use in 2019. It shows that the
Melbourne SIF clients are more likely to be younger, identify as Indigenous
Australians and report living in unstable accommodation compared to their
counterparts who did not report SIF use. Heroin was more frequently nominated
as the main drug of choice by those who reported SIF use in Melbourne than
those who did not. In Sydney those who reported SIF used were more likely to
nominate drugs other than heroin or methamphetamine as their drug of choice
than those who did not use the facility. No significant difference was found
between clients of the two sites for the use of treatment services. In Melbourne,
reports of non-fatal heroin overdose were more frequent amongst those who
reported using the SIF than those who did not. The percentages reporting a history
of incarceration or mental health problems were similar across the two samples.
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Table 1: Sociodemographic and drug use characteristics of participants who 
reported SIF use in the Melbourne and Sydney IDRS samples, 2019
USED SYDNEY MSIC
Characteristics
USED MELBOURNE MSIR Overall
No, N=67 Yes, N=85 No, N=102 Yes, N=81 Total, N=335
46 (71%) 64 (75%) Male 73 (72%) 54 (68%) 237 (72%)
46 (11) 47 (8) Age, mean(SD)* 44 (8) 40 (8)
25 (37%) 22 (27%) Indigenous* 12 (12%) 37 (46%) 96 (29%)
64 (96%) 78 (93%) Unemployed 95 (93%) 76 (94%) 313 (94%)
38 (58%) 45 (54%)
Completed any courses 
after school 31 (31%) 33 (41%) 147 (45%)
Average fortnightly 
income in $AUD
5 ( 8%) 5 ( 6%) 0-399 <5 <5 17 (5%)
52 (79%) 62 (76%) 400-999 71 (70%) 60 (76%) 245 (75%)
8 (12%) 13 (16%) 1000-1999 22 (22%) 11 (14%) 54 (16%)
<5 <5 2000+ 5 ( 5%) <5 12 (4%)
5 ( 8%) 15 (18%)
Unstable 
accommodation* 25 (25%) 32 (40%) 77 (23%)
51 (76%) 60 (71%) Ever been in prison 69 (70%) 57 (70%) 237 (72%)
32 (48%) 37 (45%)
Had mental health 
problems in the last 6 
months 43 (44%) 30 (37%) 142 (43%)
MAIN drug of choice*
45 (67%) 48 (56%) Heroin 61 (60%) 67 (83%) 221 (66%)
20 (30%) 19 (22%) Methamphetamine 25 (25%) 6 ( 7%) 70 (21%)
2 ( 3%) 18 (21%) Others 16 (16%) 8 ( 10%) 44 (13%)
44 (66%) 43 (51%)
Currently on drug 
treatment 52 (51%) 30 (37%) 169 (50%)
9 (13%) 18 (21%)
Any overdose in the last 
12months 12 (12%) 23 (28%) 62 (19%)
7 (11%) 18 (21%)
Heroin overdose in the 
last 12months 9 ( 9%) 23 (28%) 57 (17%)
*refers p-value<0.05
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Top five reasons for using the SIF 
Study participants most frequently nominated being away from police (Melbourne=53%,
Sydney=42%) and being concerned about overdose risk (Melbourne=32%, Sydney=41%) as
their reason for using the SIF. Being curious about the service in Melbourne (28%) and
concerned about using alone in Sydney (23%) were also nominated. Figure 3 illustrates the top
five reasons for using the SIF nominated by participants in Sydney and Melbourne in 2019.
Figure 3: Top five reasons 
for using the SIF among 
Melbourne and Sydney SIF 
clients, IDRS, 2019.
Use of the SIFs by the IDRS samples
Frequent use of the SIF (>50% of injections) in participants’ lifetime was reported by 19% of the
Melbourne and 22% of the Sydney sample. The distribution of injecting frequency among those
who reported using the SIFs is shown in Figure 2.
Figure 1: Proportion of injections that took 
place in the SIF, Melbourne and Sydney 
IDRS samples, 2019
Figure 2: Proportion of injections that took 
place in the SIF among participants who 
ever used SIFs, IDRS, 2019
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Conclusions
Our findings show that Melbourne MSIR clients are more likely to be younger, identify as
Indigenous and live in unstable accommodation compared to those who do not use the MSIR. In
Sydney, the differences in those who did and did not use the MSIC were less marked in the IDRS
sample. This finding may indicate that the Melbourne facility is attracting more vulnerable groups
of the target population compared to the facility in Sydney or differences in the populations of
PWID more broadly in these areas. Heroin was nominated as the drug of choice more frequently
among SIF users among the Melbourne sample; drugs other than heroin or methamphetamine in
Sydney. There were few differences in treatment utilisation. A similar percentage reported using
the facility for greater or equal to 50% of their injections in both cities. A higher percentage
reported distance as a main reason for not using the SIF in Melbourne compared to Sydney,
possibly reflecting the wider range of drug markets traditionally sampled as part of the IDRS in
Melbourne. Variation in the characteristics of participants using the two facilities requires further
research in relation to outcomes experienced such as overdose and other drug-related harms.
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Top five reasons for not using the SIF
In both the Melbourne (n=96) and Sydney (n=66) samples, the reason most frequently
nominated for not visiting the SIF was distance, ‘too far from where I live’ (Melbourne=50%,
Sydney=33%) followed by ‘too far from where I score drugs’ in Melbourne (34%) and ‘prefer to
inject at home’ in Melbourne (28%) and Sydney (33%). Figure 4 illustrates the top five reasons
for not using the SIF nominated by participants in Sydney and Melbourne in 2019.
Figure 4: Top five reasons 
for not using the SIF in 
their city among Melbourne 
and Sydney IDRS samples, 
IDRS, 2019.
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